Anna Pla
Overview
Explore the profile of Anna Pla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
34
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Granel N, Iserte G, Bartres C, Llarch N, Pla A, Sapena V, et al.
BMC Gastroenterol
. 2025 Feb;
25(1):51.
PMID: 39901067
Background: The eradication of the Hepatitis C Virus (HCV) reduce the risk of liver cancer (LC), but lifestyle changes after cure may counterbalance its benefit. Our study investigates lifestyle changes...
2.
Frigola-Capell E, Morgan R, Nogue A, Thelen I, Font J, Gonzalvo B, et al.
Rev Psiquiatr Salud Ment (Engl Ed)
. 2022 Oct;
15(3):211-212.
PMID: 36272740
No abstract available.
3.
Sanduzzi-Zamparelli M, Marino Z, Lens S, Sapena V, Iserte G, Pla A, et al.
J Hepatol
. 2021 Dec;
76(4):874-882.
PMID: 34856322
Background & Aims: Recognition of non-characterized liver nodules (NCLN) prior to direct-acting antivirals (DAAs) is associated with increased hepatocellular carcinoma (HCC) risk in patients with HCV. The risk of HCC...
4.
Egmond E, Marino Z, Navines R, Oriolo G, Pla A, Bartres C, et al.
Braz J Psychiatry
. 2019 Jul;
42(1):72-76.
PMID: 31314868
Objective: Depression has been associated with hepatitis C, as well as with its treatment with proinflammatory cytokines (i.e., interferon). The new direct-acting antiviral agents (DAAs) have minimal adverse effects and...
5.
Gambato M, Canini L, Lens S, Graw F, Perpinan E, Londono M, et al.
Liver Int
. 2018 Dec;
39(5):826-834.
PMID: 30499631
Background & Aims: Detailed hepatitis C virus (HCV) kinetics modelling is scarce in patients with advanced liver disease receiving direct-acting antivirals (DAAs). Due to budget restrictions, patients and health systems...